News | August 22, 2023
LEO Pharma to acquire Timber Pharmaceuticals
The deal represents a total transaction value of up to $36 million with an initial upfront consideration of $14 million
The deal represents a total transaction value of up to $36 million with an initial upfront consideration of $14 million
Proteolysis Targeting Chimeras (PROTACs) technology as potential new method for mosquito-borne disease control
Jeet will be a trusted partner in cardiovascular care
CiplaMed 2.0 leverages advanced analytics and automation
CrisprBits has developed a platform to build rapid, precise, and affordable POC tests for a wide range of disease and health conditions
Ryan has nearly 20 years of global legal and IP expertise in the pharmaceutical industry
Collaboration combines clinical research expertise with artificial intelligence capabilities to help drug developers better understand the probability of clinical success for their assets
AushadhAI is purposefully designed to deliver significant advantages to the pharmaceutical supply chain's key constituents
The instrument is fully integrated with Lonza’s latest WinKQCLSoftware to enable data integrity compliance, streamline training, and reduce validation burden
Reiterates India’s commitment to the BRICS TB Research Network Initiative
Subscribe To Our Newsletter & Stay Updated
